# Innovative Blood Resources, a Division of New York Blood Center, Inc. d.b.a. Memorial Blood Centers – FDA Inspection, Nov 6, 2009

Source: https://www.keypedia.com/records/fda_inspections/innovative-blood-resources-a-division-of-new-york-blood-center-inc-dba-memorial-blood-centers/8917df07-49f5-4041-ae26-bf9eedad86db
Source feed: FDA_Inspections

> FDA inspection 626034 of Innovative Blood Resources, a Division of New York Blood Center, Inc. d.b.a. Memorial Blood Centers, November 06, 2009. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 626034
- Company Name: Innovative Blood Resources, a Division of New York Blood Center, Inc. d.b.a. Memorial Blood Centers
- Inspection Date: 2009-11-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1245703 - 2024-06-27
- FDA Inspection 1066848 - 2018-09-10
- FDA Inspection 954276 - 2015-12-17
- FDA Inspection 884471 - 2014-06-13
- FDA Inspection 750333 - 2011-10-20

Company: https://www.keypedia.com/companies/innovative-blood-resources-a-division-of-new-york-blood-center-inc-dba-memorial-blood-centers/211d1586-458c-4318-bff2-526454fce9da

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d